Multiple Sclerosis, An Issue of Neurologic Clinics

Multiple Sclerosis Diagnostic Delay and Misdiagnosis<br>Recent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple Sclerosis<br>Pathophysiology, Diagnosis, Treatment and Emerging Neurotherapeutic Targets for Progressive Multiple Sclerosis: The Age of PIRA<br>Relationship Between Multiple Sclerosis, Gut Dysbiosis, and Inflammation: Considerations for Treatment<br>Updates in NMOSD and MOGAD Diagnosis and Treatment: A Tale of Two Central Nervous System Autoimmune Inflammatory Disorders<br>Advances in Multiple Sclerosis Neurotherapeutics, Neuroprotection, and Risk Mitigation Strategies<br>Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion<br>Bruton’s Tyrosine Kinase Inhibitors for Multiple Sclerosis Treatment: A New Frontier<br>Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis<br>Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis: What Is the Future of Multiple Sclerosis Treatment?<br>Leveraging Real-World Evidence and Observational Studies in Treating Multiple Sclerosis<br>Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course: Tackling the Modifiable<br>Clinical and Treatment Considerations for the Pediatric and Aging Patients with Multiple Sclerosis<br>Women’s Health and Pregnancy in Multiple Sclerosis<br>Multiple Sclerosis in Black and Hispanic Populations: Serving the Underserved<br>Era of COVID-19 in Multiple Sclerosis Care